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Introduction
Phytic acid (1,2,3,4,5,6-myo-inositol hexakisphosphate) 
is diffi  cult to digest in the gastrointestinal tract of mono-
gastric animals and humans, and is therefore considered 
as an antinutritional factor because it reduces bioavail-
ability of minerals, proteins and starch (1). Enzymatic meth-
ods of phytate degradation in foods and feeds have gained 
considerable interest, regarding their numerous advan-
tages over physical or chemical methods (2). Phyta ses, 
phosphohydrolases of myo-inositol hexakisphosphate, hy-
drolyse phytate to a pool of lower myo-inositol phos-
phates (3,4). In breadmaking, phosphorolytic activity ori-
ginates from wheat or rye fl our enzymes as well as from 
the yeast phytase (5-7). The joint action of these enzymes 
determines the fi nal profi le of inositol phosphates and 
may also lead to the formation of free myo-inositol (8). 
There are 3-phytases A (myo-inositol hexakisphosphate 
3-phos phohydrolase, EC 3.1.3.8), which start catalytic 
action at C3 atom of the myo-inositol ring, 6-phytases 
A (myo-inositol h exaphosphate 6-phosphohydrolase, EC 
3.1.3.26), which initiate the hydrolysis at the C6, and phy-
tases B (EC 3.1. 3.2), non -specifi c acid phosphomonoester-
ases (3). Generally, p hytases A are not able to hydrolyse 
phosphate residue at the C2 of the myo-inositol ring. Phy-
tase B, on the other hand, may liberate phosphorus from 
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Summary
Prepar ations of 6-phytase A (EC 3.1.3.26) and phytase B (acid phosphatase, EC 3.1.3.2) 
were applied alone and combined in the preparation of dough to estimate their catalytic 
potential for myo-inositol liberation from rye fl our in the breadmaking technology. The ex-
perimental bread samples were ground a er baking and subjected to determination of 
myo-inositol bioavailability by an in vitro method that simulated digestion in a human ali-
mentary tract, followed by measurements of myo-inositol transport through enterocyte- 
-like diff erentiated Caco-2 cells to determine its bioaccessibility. Myo-inositol content was 
measured by a high-performance anion-exchange chromatography with pulsed ampero-
metric detection (HPAEC-PAD) technique. The concentration of myo-inositol in the dialy-
sates of control bread was 25.3 µg/mL, whereas in the dialysates of bread sample baked 
with 6-phytase A, the concentration increased to 35.4 µg/mL, and in the bread baked with 
phytase B to 64.98 µg/mL. Simultaneous application of both enzymes resulted in myo-ino-
sitol release of 64.04 µg/mL. The highest bioaccessibility of myo-inositol, assessed by the 
measurement of the passage through the Caco-2 monolayer was determined in the bread 
baked with the addition of 6-phytase A. Enzymatically modifi ed rye bread, particularly by 
the addition of 6-phytase A, may be therefore a rich source of a highly bioaccessible myo- 
-inositol.
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any position and therefore concurrent action of phytase A 
and phytase B may lead to almost complete dephosphor-
ylation of phytate, and generation of substantial amounts 
of myo-inositol (4). Myo-inositol is hexahydroxylic cyclo-
hexane derivative present in all types of living cells, in 
concentrations varying from 0.03 mM in human plasma 
to 3 mM in brain tissue, cerebrospinal fl uid, foetal serum 
and human milk (9). The content in human diet oscillates 
between 0.8 and 1 g per day, more than half of this com-
pound in the form of inositol phospholipids. Decreased 
levels of myo-inositol are associated with the risk of cata-
racts, retinopathy, and neuropathy development (10). 
Studies on rodents and humans demonstrated that myo-
inositol was eff ective in treating diabetes and may be a 
suitable marker for mass screening of diabetes, insulin re-
sistance and glucose intolerance (11,12). Larner et al. (13) 
proposed a new model of insulin signalling with inositol 
glycans as putative second messengers. Kim et al. (14) 
found this substance to be eff ective in inducing the re-
sponse of macrophages to bacterial infections and other 
infl ammatory conditions. Okazaki and Katayama (15) 
found that myo-inositol prevented accumulation of fat in 
the liver of rats intoxicated with DDT. This compound 
also regulates fat metabolism in the myocardium of rats 
with chemically induced diabetes (16). Myo-inositol is 
also known to exert positive eff ects in the treatment of 
psychiatric disorders (17), and is also involved in several 
aspects of human reproduction (18). Remarkably, some 
reports indicate that mixtures of myo-inositol and phytate 
are more eff ective in cancer cell elimination than these 
substances administered separately (19,20). In the litera-
ture, there are reports that clearly indicate bioactive prop-
erties of this compound, which suggests that supplemen-
tation of foods with myo-inositol might be a proper way 
to modulate sugar and lipid metabolism in humans. The 
strategy presented here is based on the concept of enzy-
matic conversion of endogenous phytates of rye fl our into 
myo-inositol by means of commerci al microbial phytases 
added to the dough. Although phytase application in the 
breadmaking has been studied by a few researchers (5-
7,21), there is no evidence to suggest that this can be uti-
lized as a method for producing bread with enhanced 
myo-inositol content.
The objectives of the current study are therefore to as-
sess the impact of the addition of 6-phytase A and phy-
tase B, alone or in combination, to the dough on the bio-
availability of myo-inositol from rye bread by an in vitro 
procedure simulating digestion in human alimentary 
tract. Also, its bioaccessibility is determined by the mea-
surement of an uptake by the Caco-2 cell monolayer.
Materials and Methods
Enzymes
The preparation of 3-phytase A (Natuphos®) was ob-
tained from BASF, Ludwigsh afen, Germany, 6-phytase A 
(Ronozyme® NP) was a product of Novozymes, Bag gs-
værd, Denmark, and phytase B (Finase® AP) of AB En-
zymes, Rajam äki, Finland. Pepsin and pancreatin were 
purchased from Sigma Chemical Co (St. Louis, MO, 
USA). Acid phosphatase activity was determined at 40 °C 
by incubating the enzyme with 5.5 mM solution of sodi-
um p-nitrophenylphosphate at pH=4.5 for 15 min. The 
unit of acid phosphatase activity (APAU) was defi ned as 
the amount of enzyme which, under the reaction condi-
tions, liberates 1 µmol of p-nitrophenol during 1 min. One 
unit of phytase A activity (PAU) was defi ned as the 
amount of enzyme that liberates 1 µM of inorganic phos-
phorous from 2 mM of sodium phytate in 1 min at 40 °C, 
pH=4.5.
Breadmaking procedure
Wholemeal rye bread was baked using the following 
recipe for dough preparation: 1000 g of wholemeal rye 
fl our type 2000 from Podlaskie Młyny Wodne (Tokary, Po-
land), 80 g of an acidifi er from Bionat S.A. (Kraków, Po-
land), 50 g of lyophilized baker’s yeast from Lesaff re P.S. 
(Łódz, Poland) and 30 g of table salt from POCh (Gliwice, 
Poland) were mixed with 720 mL of tap water. Experi-
mental dough consisted of the above components, but 670 
mL of tap water and 50 mL of 0.05 M acetate buff er 
(pH=4.5) was used. Appropriate amounts of enzyme 
preparations were diluted in the acetate buff er to obtain 
30 APAU or 5000 PAU per kg of fl our. The dough ingredi-
ents were mixed for 9 min and then dough pieces of 250 g 
were form ed, put in metal forms and placed in a fermen-
tation chamber at 35 °C and constant moisture. A er 150 
min, fermented dough samples were transferred to an 
oven preheated to 260 °C. A er 30 min, the loaves were 
removed from the oven and le  for 2 h to cool. Baking 
procedures were performed in triplicates and included a 
control bread in each run.
In vitro procedure
Bioavailability of myo-inositol was estimated by an in 
vitro technique according to the method developed by 
Zyla et al. (22) and subsequently modifi ed by Starzyńska- 
-Janiszewska et al. (23) to simulate the conditions of hu-
man gastrointestinal tract. Half a gram of samples of 
bread was incubated with 1.7 mg of pepsin (Sigma-Al-
drich, Steinheim, Germany; the declared activity was 
4750 U/mg) dissolved in 0.1 mol/L HCI at 37 °C, pH=2.0, 
for 2 h. Next, 2.5 mg of pancreatin (Sigma-Aldrich, from 
porcine pancreas, 8 × United States Pharmacopeia) dis-
solved in 0.1 mol/L of NaHCO3 were added and the whole 
samples were incubated in dialysis tubes (Sigma-Aldrich, 
cellulose membrane 25 mm ×16 mm) at 37 °C, pH=7.0, for 
4 h. These incubations simulated the digestion in the 
stomach and small intestine, respectively.
Cell culture
The human colorectal carcinoma cell line, Caco-2, 
was cultured in Dulbecco’s modifi ed Eagle’s medium 
(DMEM) supplemented with 10 % of foetal bovine serum 
(FBS Gold, PAA Laboratories GmbH, Cölbe, Germany) 
with antibiotics and antimycotics (PAA Laboratories 
GmbH). Cultures were passed when they had reached 
50 % confl uence and 5·105 of cells were seeded on the po-
rous membranes of cell culture inserts (BD Falcon trans-
parent inserts for a 12-well plate, pore diameter 0.4 µm, 
1.6·106 pores/cm2, BD (Becton, Dickinson and Compan y), 
Franklin Lakes, NJ, USA). The full diff erentiation to en-
terocyte-like cells was achieved a er sebsequent two 
weeks of culture. The quality of epithelial layers was reg-
ularly monitored by measuring their transepithelial elec-
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trical resistance (TEER) with epithelial voltohmmeter 
(EVOM, World Precision Instruments, Sarasota, FL, USA). 
One day before the experiment, the media were changed 
to serum-free DMEM (SF-DMEM) supplemented with 
0.2 % of bovine serum albumin (BSA) in all wells. Cells 
were serum-starved for 24 h, then 250 µL of bread dialy-
sates were added to the apical chambers along with 250 
µL of SF-DMEM. In the in vitro control treatment, blanks 
were used instead of a bread dialysate in the in vitro pro-
cedure. Basolateral chambers were fi lled with 1 mL of 
myo-inositol-free SF-DMEM (Institute of Immunology 
and Experimental Therapy, Wroclaw, Poland). A er 48 h, 
the media were collected from the basolateral and apical 
chambers, centrifuged at 1000 ×g for 5 min, and frozen at 
-80 °C for future analysis.
Chromatographic system and detection
Analysis of myo-inositol phosphates in 
bread samples
Extraction of inositol phosphates from bread samples 
was conducted according to Gambuś et al. (24). Profi les of 
the isomers of myo-inositol phosphates were analyzed on 
the Ultimate 3000 system (Dionex Corporation, Sunny-
vale, CA, USA) using high-performance anion excha nge 
chromatography (HPAEC) with postcolumn derivatiza-
tion and spectrophotometric detection, as described earli-
er (25).
Analysis of myo-inositol in dialysates
Chromatograms were generated using HPLC column 
Rezex™ RCM Ca2+ (375 mm × 4 mm i.d., Phenomenex, Tor-
rance, CA, USA ) for comprehensive analysi s of monosac-
charides and sugar alcohols fi lled with sulphonated sty-
rene-divinylbenzene beads in cross-linked polymer (8 %) 
in cationic form (Ca2+). The detection was performed using 
the pulsed amperometric detector (PAD). Analyses were 
carried out at 25 °C with fl ow rates of 0.6 mL/min using de-
ionized water as an eluent a er postcolumn modifi cation 
with sodium hydroxide (200 mM, fl ow rate of 0.15 mL/
min) (26). The HPLC experiments were done in triplicate.
Analysis of myo-inositol in conditioned cell culture 
media
Chromatograms were generated using Dionex Car-
boPac™ MA1 HPLC column (250 mm × 4 mm i.d., Dionex 
Corporation) and the PAD detection system. Analyses 
were carried out at 25 °C with fl ow rates of 1 mL/min us-
ing linear gradient of deionized water and 1 M NaOH as 
the eluent according to the Dionex AN67 brochure. HPLC 
experiments were done in triplicates. Two diff erent meth-
ods were used in the analysis. The Rezex™ RCM column 
(Phenomenex) allowed for a be er separation of stereo-
isomers, chiro- from myo-inositol in the dialysates from 
the in vitro method, whereas direct detection of myo-inosi-
tol on the CarboPac MA1 column by the HPAEC-PAD 
procedure was more sensitive in the case of myo-inositol 
determination in the cellular fl uids.
Statistical analysis
Experimental data were subjected to the one-way 
ana lysis of variance (ANOVA) to detect signifi cant diff er-
ences among the results and expressed as a mean value± 
standard error of mean (SEM). The signifi cance of diff er-
ences was checked by the Tukey’s test using STATISTICA 
for Windows, v. 10 (StatSo  Inc., Tulsa, OK, USA) statisti-
cal so ware.
Results and Discussion
Loaves of rye bread baked from dough samples with 
the addition of either 6-phytase A (5000 PAU per kg of 
fl our) or phytase B (30 APAU per kg of fl our), or a combi-
nation of 6-phytase A with phytase B were analyzed by 
the in vitro procedure that simulated gastric and intestinal 
digestion in humans to assess bioavailability of myo-inosi-
tol. Signifi cant diff erences among concentrations of dia-
lysable myo-inositol released from bread samples in the in 
vitro simulation of multiple digestions were observed 
(Fig. 1). The generation of myo-inositol in the control 
bread samples was probably caused by the activity of en-
dogenous phytases from rye and yeast phytases. In sam-
ples of control bread baked without enzymes the concen-
tration of dialysable myo-inositol was 25.3 µg/mL, in the 
dialysates of bread baked with 6-phytase A 35.49 µg/mL, 
whereas in bread supplemented with phytase B, myo-ino-
sitol concentration was almost 2.56-fold higher (64.98 µg/
mL). However, simultaneous application of both phytases 
during breadmaking (6-phytase A at 5000 PAU per kg of 
fl our and phytase B at 30 APAU per kg of fl our) did not 
enhance dialysable myo-inositol (64.04 µg/mL) above the 
level obtained with phytase B used as a sole supplemental 
enzyme. Phytase B as unspecifi c acid phosphatase most 
probably releases phosphates in a random way, propor-
tionally decreasing the level of existing inositol phos-
phates in rye bread and liberating free myo-inositol. In the 
presence of phytase A, however, the levels of myo-inositol 
were not higher and the fi nal products were detected as 
inositol mono- (IP1) and diphosphates (IP2).
Fig. 1. Concentrations of myo-inositol in the dialysates of enzy-
matically modifi ed loaves of bread subjected to the in vitro pro-
cedure of multiple digestions measured by the HPLC-PAD 
method. Control bread=rye bread made without enzyme addi-
tion, 6-phytase A=bread supplemented with 6-phytase A at 
5000 PAU/kg fl our, phytase B=bread made from dough supple-
mented with phytase B at 30 APAU/kg fl our, phytase B+6-phy-
tase A=rye bread supplemented with both phytases. PAU=phy-
tase A activity units, APAU=phytase B activity units. Diff erent 
le ers denote statistical diff erence at p≤0.05
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In the next step, bioaccessibility of myo-inositol was 
assessed by measuring the transport of this compound 
through the monolayer of the Caco-2 cells. Schematic dia-
gram of the cell culture procedure is depicted in Fig. 2. 
This cell line derived from colonic adenocarcinoma sur-
prisingly well mimics intestinal cell behaviour upon long 
culture. The fortnight culture of these cells on porous 
membranes of inserts leads to the creation of an impervi-
ous epithelial layer of polarized cells which resemble ma-
ture enterocytes (27). Tissue culture tests provide a rela-
tively quick and cost-eff ective tool for predicting the 
absorption of bioactive components by assessing the 
probability of their transport through epithelial layer (28).
These tests are o en a reasonable alternative to in vivo 
studies on laboratory animals (e.g. rats) in the analysis of 
the phytate conversion; however, it should be taken into 
account that phytase activity in rodent small intestine is 
30-fold higher than in human tissue. In the control experi-
ment three concentrations of myo-inositol were used (0, 25 
and 50 µg/mL) to demonstrate a relationship between the 
myo-inositol transport rate and its concentration (Fig. 3). 
The uptake of myo-inositol by Caco-2 cell line was found 
to depend on the myo-insoitol concentration, which is in 
agreement with the literature data describing two main 
sodium/myo-inositol cotransporters (29). The fl uid from 
basolateral chambers of inserts from Caco-2 monolayers 
exposed for 48 h to the digest of bread supplemented 
with phytase B and the fl uid from the same chamber be-
fore the addition of the digest were analyzed. Caco-2 cells 
exposed to the dialysates from digests of bread absorbed 
myo-inositol from the apical chambers and then secreted 
it to the basolateral chambers of the inserts.
To our knowledge, this is the fi rst evidence of myo- 
-inositol transport across Caco-2 monolayers. The amounts 
of myo-inositol secreted to the basolateral chambers from 
the inserts not exposed (control in vitro) and exposed to 
the bread digests for 48 h, also expressed as a percentage 
of the initial amounts of myo-inositol in apical chambers, 
are given in Table 1. Total amounts of myo-inositol deter-
mined in both the apical and the basolateral chambers at 
the beginning of the experiment were subtracted from the 
total amounts of this compound determined a er 48 h of 
the Caco-2 cell culture.
The initial myo-inositol amounts in the apical cham-
bers diff ered among treatments because a standardized 
volume of 0.25 mL of the bread digests or of the reagents 
used in the in vitro procedure (the control in vitro treat-
ment), mixed with 0.25 mL of the DMEM solution, was 
applied on the inserts. Generally, no close relationship 
was found between myo-inositol amounts in the apical 
and basolateral chambers of the inserts, which may sug-
gest that specifi c transport mechanisms rather than pas-
sive diff usion phenomena were active in the myo-inositol 
monolayer metabolism. The highest amounts of myo-ino-
sitol were released from the Caco-2 cells immersed in the 
digests of bread modifi ed with the addition of 6-phytase 
A, whereas signifi cantly lower amounts of this compound 
were determined in the basolateral chambers of inserts 
fi lled with the dialysate of bread made with phytase B. 
The amounts of myo-inositol determined in the basolater-
Fig. 2. Schematic diagram of the cell culture. Caco-2 cells were 
cultured for two weeks on the porous membrane which sepa-
rates apical and basolateral chambers of the insert to obtain 
continuous monolayer of diff erentiated cells. Myo-inositol or 
dialysates of bread were added from the apical side diluted 
(1:1) in 0.5 mL of myo-inositol-free SF-DMEM medium. A vol-
ume of 1 mL of myo-inositol-free DMEM medium was poured 
into the basolateral part. A er 48 h the media were collected 
from both chambers to estimate the paracellular fl ow of myo-
inositol. The consistence of monolayers was monitored by mea-
suring the TEER values at the beginning and the end of incuba-
tion period. TEER=trans epi thelial electrical resistance
Fig. 3. Control experiment: transport of the myo-inositol through 
Caco-2 monolayer a er 48 h. Total amounts of myo-inositol de-
termined by HPAEC-PAD in both the apical and the basolateral 
chambers at the beginning of the experiment compared to the 
total amounts of this compound determined a er 48 h of the 
Caco-2 cell culture. MI-0, MI-25 and MI-50=initial concentra-
tions of myo-inositol in the solutions of 0, 25, 50 µg/mL, respec-
tively, were diluted at the ratio of 1:1 with myo-inositol-free SF- 
-DMEM medium
Table 1. Amounts of myo-inositol in the basolateral chambers of 
the inserts a er 48 h of Caco-2 culture and as a percentage of 





      γ(myo-inositol)AC  
/%
control in vitro     (5.2±0.40)a   (130.5±14.0)c
control bread   (9.3±0.4)a (149.1±1.2)c
6-phytase A (14.7±0.4)c  (123.3±2.8)bc
phytase B (11.9±0.3)b   (61.3±0.4)a
phytase B + 
6-phytase A (12.40±0.09)
b   (65.9±1.7)a
Mean values followed by diff erent le ers in superscript are 
signifi cantly diff erent (p<0.05)
BC=basolateral chamber, AC=apical chamber
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al chambers a er 48 h of Caco-2 culture accounted for 123 
%, and for 61 % of its initial amounts in the apical cham-
bers fi lled with the digests of bread made with the addi-
tion of 6-phytase A, and phytase B, respectively.
It se ems possible that Caco-2 cells dephosphorylated 
myo-inositol phosphate intermediates generated by 6-phy-
tase A, but were unable to degrade lower myo-inositol 
phosphates produced by the catalytic action of phytase 
B. Such hypothesis should be considered because these 
enzymes are known to release two distinct pools of myo- 
-inositol phosphates during their action on myo-inositol 
hexa kisphosphates (phytates). The profi les of myo-inosi-
tol phos phates analyzed by HPAEC in the enzyme-modi-
fi ed bread shown in Table 2 may serve as a confi rmation 
of the hypothesis mentioned above. In bread supplement-
ed with phytase B the main fraction is inositol phosphate 
with 3 to 4 phosphorus moieties, but in the bread made 
with the addition of 6-phytase A, these were inositol di- 
and triphosphates. The application of both phytases re-
sulted in bread samples whose digests infl uenced Caco-2 
metabolism similarly as in the case of bread baked with 
phytase B alone. The explanation of this phenomenon is 
similar to the situation observed in determination of myo-
inositol in bread subjected to in vitro procedure.
An additional evidence of a substantial diff erence in 
myo-inositol metabolism in Caco-2 cells subjected to di-
gests from the bread supplemented with 6-phytase A and 
that supplemented with phytase B is provided in Fig. 4, 
where the net changes in myo-inositol mass in both apical 
and basolateral chambers of the inserts in the course of 
48-hour culture are shown. In the in vitro control, control 
bread and 6-phytase A treatments, myo-inositol was syn-
thesised by the Caco-2 cells most probably due to the ac-
tion of cellular phosphatases on lower myo-inositol phos-
phates, but in the treatments where the digest contained 
the products of phytase B, myo-inositol consumption or 
degradation was evidenced. It can be postulated, there-
fore, that in contrast to 6-phytase A, the action of phytase 
B on the dough components of rye bread must have pro-
duced compounds which negatively aff ected myo-inositol 
bioaccessibility.
While phytase B seems to be the key activity that de-
termines myo-inositol bioavailability from rye bread, 
6-phytase A caused the highest enhancement in its bioac-
cessibility. Suzuki et al. (30) observed that phytate hydro-
lysates, especially myo-inositol triphosphates, were able 
to induce intracellular signalling in the Caco-2 cell line, 
and myo-inositol phosphate synthase (MIPS) is known to 
be regulated by phosphorylation (31). It could not be ex-
cluded that physiologically benefi cial distribution of myo-
-inositol triphosphates generated by 6-phytase A stimu-
lated Caco-2 cells to synthesize and eff ectivelly secrete 
myo-inositol, thus enhancing its bioaccessibility. Shockra-
vi et al. (21) studied iron and zinc bioaccessibility from 
breads made from fl our with diff erent extraction rates 
and dephytinized by Aspergillus niger 3-phytase A during 
in vitro digestion. As a result of phytase application, they 
reported substantial improvements in bioaccessibility of 
iron and zinc determined in the Caco-2 cell line.
The current study confi rms that myo-inositol is re-
leased during hydrolysis of fl our phytates in this individ-
ual bread-making process more effi  ciently by phytase B 
than by 6-phytase A. The 6-phytase A, however, generates 
myo-inositol which is signifi cantly more bioaccessible. Myo - 
-inositol is known to exert multiple physiological eff ects 
that are manifested by antioxidant, immunostimulating 
and antidepressant properties (9,32). Many important 
questions regarding dephosphorylation of phytases in ce-
reals have not been addressed yet. This study contributes 
to the development of an entirely new and innovative ap-
proach in breadmaking, involving the enzymatic conver-
sion of phytates, which have antinutritional properties, 
into myo-inositol – a biostimulating and health-promoting 
compound.
Conclusions
The application of proper phytate-degrading en-
zymes in the technology of rye breadmaking leads to gen-
Fig. 4. Myo-inositol balance a er 48 h of culture of the Caco-2 
monolayers. Total amounts of myo-inositol determined in both 
the apical and the basolateral chambers at the beginning of the 
experiment were subtracted from the total amounts of this com-
pound determined a er 48 h of the Caco-2 cell culture. In vitro 
control=culture medium without bread sample addition, con-
trol bread=rye bread made without enzyme addition, 6-phytase 
A=bread supplemented with 6-phytase A at 5000 PAU per kg of 
fl our, phytase B=bread supplemented with phytase B at 30 APAU 
per kg of fl our, phytase B+6 phytase A=rye bread supplemented 
with both phytases. Signifi cant diff erences between the fi nal 
and initial myo-inositol mass at *p<0.01 and **p<0.001
Table 2. Profi le of myo-inositol phosphates in rye bread supple-
mented with phytases analysed by HPAEC
Sample
Inositol phosphate fraction/%
IP2 IP3 IP4 IP5 IP6
6-phytase A 35.43 30.69 3.44 4.33 24.63
phytase B   9.44 21.99 42.97 4.83 20.77
phytase B + 
6-phytase A 27.14 33.99 26.78 2.95   9.14
control bread 16.22 27.97 38.09 8.47   9.25
IP2=myo-inositol diphosphate, IP3=myo-inositol triphosphate, 
IP4=myo-inositol tetraphosphate, IP5=myo-inositol pentaphos-
phate, IP6=myo-inositol hexaphosphate
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eration of myo-inositol – a component with bioactive, 
health-promoting eff ects. Its actions include insulin sensi-
tivity modulation, regulation of cholesterol metabolism, 
central nervous and reproduction system development 
and maintenance, as well as regulation of the bone calcifi -
cation processes. Simultaneous application of phytase A 
and phytase B or phytase B alone to the dough leads to 
the release of 2.4-fold higher amounts of bioavailable 
myo-inositol, as assessed by an in vitro procedure which 
simulates digestion in the human intestine. Determina-
tion of bioaccessibility of this compound by the measure-
ment of an uptake by Caco-2 cell monolayer revealed that 
6-phytase A was the most eff ective enzyme in enhancing 
the amount of bioaccessible myo-inositol in the experimen-
tal bread. Enzymatically modifi ed rye bread may there-
fore be a rich source of bioavailable and bioaccessible 
myo-inositol. Enzymatic generation of myo-inositol seems 
to be a promissing alternative to a strategy of food sup-
plementation with health-promoting components.
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